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SUMMARY 
The basic theme of the dissertation is components of methionine and lipid metabolism 
including homocysteine, choline and betaine, and their relation to nutrition and cardiovascular 
disease (CVD) risk factors. Established predictors of plasma total homocysteine (tHcy) 
include several CVD risk factors and B-vitamins, while information is scarce regarding 
predictors of plasma choline and betaine. The aim of this study was to examine the role of 
diet, lifestyle and other CVD risk factors in prediction of plasma choline and betaine in a 
large population-based study. The study population included 7074 men and women aged 47-
49 and 71-74 years who participated in the Hordaland Health Study conducted in 1997-1999.  
 
Plasma tHcy levels were inversely related to the intake of fruit and vegetables, bread, fish, 
non-processed meat and eggs and positively related to products rich in sugar and fat. High 
intakes of saturated, monounsaturated and polyunsaturated fat were related to higher tHcy, 
with the exception of very long chain n-3 fatty acids [VLC n-3 FA] which was inversely 
related to plasma tHcy. The latter association may be explained by simultaneous consumption 
of B-vitamins and by increased plasma betaine concentration. 
 
Plasma choline was positively associated with the intake of eggs, low fat-milk and beer and 
inversely related to the intake of legumes, sugar products and coffee. Plasma choline was 
determined by only one nutrient, cholesterol.  
 
Plasma betaine was positively associated with the consumption of bread and tea, and 
inversely associated with sugar- and fat-rich products, non-processed meat and alcohol. 
Saturated and monounsaturated fat was inversely and VLC n-3 FA positively related to 
plasma betaine. The latter association was confounded by dietary folate, vitamin supplement 
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use and physical activity, perhaps reflecting a healthier lifestyle among individuals 
consuming VLC n-3 FA. In addition, betaine was positively related to total energy intake. A 
dietary pattern high in fat and sugar was associated with lower betaine concentration.  
 
Plasma choline and betaine were associated with CVD risk factors including major 
components of the metabolic syndrome. Choline was positively associated with serum 
triglycerides (TGs), glucose and body fat, and inversely related to HDL cholesterol and 
smoking. Betaine was inversely associated with serum non-HDL cholesterol, TGs, body fat 
and blood pressure, and positively associated with HDL cholesterol and physical activity. 
Thus, an unfavourable cardiovascular risk factor profile was associated with high choline and 
low betaine concentrations. Divergent associations with choline and betaine may be explained 
by a disruption of the mitochondrial choline dehydrogenase pathway under conditions of 
mitochondrial dysfunction in the metabolic syndrome. 
 
Diet influences the concentrations of both plasma tHcy and betaine. A diet low in B-vitamins 
and with a high content of saturated fat and sugar may decrease betaine and increase tHcy 
levels. On the other hand, a diet rich in B-vitamins and VLC n-3 FAs may increase betaine, 
leading to decreased tHcy concentrations and hence, decrease the risk for CVD. 
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ABBREVIATIONS                     
BD 
 
Betaine aldehyde dehydrogenase 
BB2 Riboflavin 
 
BB6 Vitamin B6
 
BB12 
 
Cobalamin 
Bet 
 
Betaine 
BHMT 
 
Betaine homocysteine methyltransferase 
BMI Body mass index 
 
CD 
 
Choline dehydrogenase 
CDP-Cho 
 
 Cytidine diphosphocholine 
Cho 
 
Choline 
CI Confidence interval 
 
CH2THF 
 
Methylenetetrahydrofolate 
CH3THF 
 
Methyltetrahydrofolate 
CT CTP: phosphocholine cytidylyltransferase  
 
CVD   Cardiovascular disease 
 
Cys 
 
Cysteine 
Cysta 
 
Cystathionine 
 
DMG 
 
Dimethylglycine 
HDL 
 
High density lipoprotein 
HHS The Hordaland Homocysteine Study 
 
HUSK The Hordaland Health Study 
 
LDL 
 
Low density lipoprotein 
Met 
 
Methionine 
MS 
 
Methionine synthase 
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MTHFR 
 
Methyltetrahydrofolate reductase 
MUFA Mono-unsaturated fatty acids 
 
PE 
 
Phosphatidylethanolamine 
PEMT Phosphatidylethanolamine methyltransferase 
 
PUFA Poly-unsaturated fatty acids 
 
PC 
 
Phosphatidylcholine 
P-Cho 
 
Phosphocholine 
S-AdoMet 
 
S-adenosylmethionine 
S-AdoHcy 
 
S-adenosylhomocysteine 
SD Standard deviation 
 
SFA       Saturated fatty acids 
 
TG 
 
Triglycerides 
THF 
 
Tetrahydrofolate 
tHcy Total plasma homocysteine 
 
VLC n-3 FA Very long chain n-3 fatty acids 
 
VLDL 
 
Very low density lipoprotein 
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DEFINITIONS 
Apoprotein Protein component of the lipoprotein shell, which increases the 
water solubility of the lipoprotein. 
 
Blood lipoprotein Water-soluble macromolecules. Each lipoprotein particle is 
composed of a core of hydrophobic lipids such as cholesterol 
esters and triacylglycerols surrounded by a shell of polar lipids 
(the phospholipids).  
 
Cardiovascular disease CVD is caused by disorders of the heart and blood vessels, and 
includes coronary heart disease, cerebrovascular disease, 
increased blood pressure (hypertension), peripheral artery 
disease, rheumatic heart disease, congenital heart disease and 
heart failure. 
 
Diabetes mellitus A disorder of carbohydrate metabolism in which sugars in the 
body are not oxidized to produce energy due to lack of the 
pancreatic hormone insulin. The accumulation of sugar leads to 
its appearance in the blood (hyperglycaemia), then in the urine. 
 
Diabetes mellitus, type 2  Noninsulin dependent DM, which usually occurs after the age of 
40, the pancreas retains some ability to produce insulin but this is 
inadequate for the body’s needs; alternatively, the body becomes 
resistant to the effects of insulin. 
 
Essential nutrient No biochemical pathways exist for the synthesis of this nutrient 
in humans, and hence this nutrient is only obtained from diet. 
 
Glucose intolerance Abnormal glucose tolerance 
 
Insulin Protein hormone, produced in the pancreas by the beta cells of 
the islets of Langerhans, which is important for regulating the 
amount of sugar (glucose) in the blood. 
 
Insulin resistance A state (of a cell, tissue, system, or body) in which greater-than-
normal amounts of insulin are required to elicit a quantitatively 
normal response. 
 
Methionine metabolism The sum of the biochemical changes undergone by methionine in 
the body. 
 
Metabolic syndrome  Constellation of lipid and non-lipid risk factor of metabolic 
origin: obesity, elevated blood pressure, impaired fasting glucose, 
and high TG and low HDL cholesterol concentrations. 
 
Monounsaturated fatty 
acids 
 
Contain one double bond between the carbons in the chain. 
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Polyunsaturated fatty 
acids 
 
Fatty acids with two or more double bonds between the carbons 
in the chain. 
Saturated fatty acids Have single bonds between the carbons in the chain. 
 
Unsaturated fatty acids Contain one or more double bonds between carbons in the chain. 
 
Very long chain n-3 fatty 
acids 
Polyunsaturated fatty acids with 18-28 carbon atoms in the chain. 
The first double bond occurs between the 3rd and the 4th 
carbons. 
 
Very low density 
lipoprotein 
Is produced in the liver, mainly from dietary carbohydrate, and 
secreted into the blood. VLDL transports endogenously 
synthesized lipids to the tissues. VLDL particles are denser, as 
they contain a lower percentage of triglyceride than do the 
chylomicrons. 
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1    INTRODUCTION 
Modifiable risk factors for cardiovascular disease 
CVD is the number one cause of death in individuals over 60 years globally and this is 
projected to continue (1). An estimated 17.5 million people died from CVD in 2005, 
representing 30% of all global deaths. Of these deaths, 7.6 million were due to heart attacks 
and 5.7million were due to stroke. Heart attacks and strokes are mainly caused by a blockage 
that prevents blood flow to the heart or to the brain, mostly caused by build-up of fatty 
deposits in the blood vessel walls. The most important modifiable risk factors for heart 
disease and stroke are cigarette smoking, unhealthy diet and physical inactivity, responsible 
for about 80% of CVD. The effect of unhealthy diet and physical inactivity may be raised 
blood pressure, increased blood glucose and lipid levels, as well as overweight and obesity. 
These are sometimes referred to as ‘intermediate risk factors’ for CVD.  
 
The World Health Organization (WHO) has defined overweight and obesity in adults as body 
mass index (BMI) of 25.0-29.9 kg/m2 and > 30.0 kg/m2 , respectively (1, 2). Overweight and 
obesity have reached epidemic proportions globally along with an adoption of a westernized 
lifestyle characterized by a combination of excessive food intake and inadequate physical 
activity (1, 3). The dramatic rise in the prevalence of obesity has been accompanied by 
increases of incidence and prevalence of type 2 diabetes (2). Findings from epidemiological 
studies have repeatedly confirmed a strong positive association between excess adiposity and 
risk of developing type 2 diabetes (1). Because obesity and diabetes are major causes of 
morbidity and mortality, reversing the obesity and diabetes epidemics is of utmost importance 
(1). The increasing prevalence of obesity and diabetes in most parts of the world has imposed 
an enormous burden on health care systems, and this is expected to escalate in the future. 
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Homocysteine, choline and betaine and the risk for disease 
Homocysteine 
Elevated plasma total homocysteine (tHcy) concentration has been related to several adverse 
conditions and diseases (4, 5) including adverse pregnancy outcomes (6, 7), cognitive 
dysfunction among the elderly (8, 9) and osteoporosis (10, 11). Plasma tHcy is also a risk 
factor for CVD in prospective studies (12-15), and several studies have found associations 
between tHcy and coronary disease, cerebrovascular complications and peripheral arterial 
disease (16-21). While supplementation with B-vitamins effectively lowers tHcy 
concentrations, interventional trials with B-vitamin supplementation have failed to reduce risk 
in patients with established CVD, but there seems to be a beneficial effect in stroke (22-28). 
 
Choline 
Previous studies have reported that choline supplementation reduces tHcy (29, 30), and 
increases blood triglycerides (31). Although a few prospective studies have showed that 
dietary choline intake is not associated with CVD risk reduction (32, 33), the relation between 
choline and CVD is not clear. Experimental studies have found that choline deficiency is 
associated with non-alcoholic fatty liver disease (34, 35), which is common in obesity, type 2 
diabetes mellitus and the metabolic syndrome (36, 37).   
 
Betaine 
Dietary supplementation with betaine may substantially decrease tHcy concentration (38-40), 
especially after methionine loading (when folate supplementation does not lower tHcy) (40-
42). The reduction of tHcy by betaine supplementation is accompanied by increased LDL 
cholesterol and total/HDL cholesterol ratio (31, 43), while no effect on body composition and 
weight was seen in one study (39). Longitudinal observational studies found no association 
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between dietary betaine intake and CVD risk (32, 33). Little is known about the role of 
plasma betaine in disease, although increased BMI, body fat and plasma ApoB have been 
related to lower plasma betaine in patients attending a lipid clinic (44).  
 
Biological function of homocysteine, choline and betaine 
Homocysteine 
Homocysteine (Hcy) is a non-protein sulfhydryl-containing amino acid in human tissues and 
plasma, and its only dietary precursor is the essential amino acid methionine. Plasma tHcy is a 
marker of folate status. In addition, via endogenous synthesis of phosphatidylcholine, 
homocysteine is related to lipoprotein synthesis and lipid metabolism (45).  
 
Choline 
Choline, which is an epigenetic regulator of gene expression (46), has a variety of other 
biological functions. It is a precursor of lipoproteins, membrane phospholipids and the 
neurotransmitter, acetylcholine; is therefore important for lipid metabolism, the integrity of 
cell membranes and nerve function (47). Phosphatidylcholine (lecithin, [PC]) is the most 
abundant choline derivative in humans (48), present in most human cells and tissues (49). 
Thus, choline is needed for the growing body, for brain development and function, lifelong 
memory function, normal muscle function, and it may influence the risk for neural tube 
defects (50-52).  
 
In addition, phosphatidylcholine is required for the synthesis and secretion of very low-
density lipoproteins (VLDL) to blood. VLDL transport fatty acids (FAs) in the form of TGs 
from the liver to peripheral tissues. FAs are an important source of fuel for muscles and they 
are oxidized for energy in muscular mitochondria or stored in adipose tissue. After 
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supplementation with PC the level of plasma TGs may be increased (29). On the other hand 
choline deficiency may also lead to increased TGs in liver and fatty liver disease (35, 48, 53, 
54). Recently, choline has been considered as an essential nutrient for humans (48, 49, 51, 52) 
and recommended dietary allowances have been published (50, 55).  
 
Betaine 
Betaine has two functions in humans. First, it is an organic osmolyte that accumulates in a 
variety of cells, including renal medullary cells, under condition of hypertonicity (56). 
Secondly, it serves as a methyl donor in the betaine-homocysteine methyltransferase (BHMT) 
reaction (57), which is responsible for the betaine-dependent remethylation of homocysteine 
to methionine. This explains the inverse relationship between plasma tHcy and plasma betaine 
(41, 58), and why plasma concentration of tHcy decreases after betaine supplementation (42). 
Compared to folate, betaine supplementation may substantially reduce homocysteine after a 
methionine load (41) and this effect is stronger in individuals with the MTHFR TT genotype 
(58).  
 
One-carbon metabolism 
Figure 1 provides an overview of the link between methionine (Met) and lipoprotein 
metabolism, with emphasis on components related to tHcy, betaine and choline. Choline and 
betaine are obtained from food or synthesized de novo. PC is formed endogenously from 
phosphatidylethanolamine (PE) by a S-adenosylmethionine(S-AdoMet)-dependent 
methylation reaction catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT). 
This is a significant source of choline relative to dietary intake. Hcy is formed during the S-
adenosylhomocysteine(S-AdoMet)-dependent methylation of PE to PC. Three molecules of 
S-AdoMet are required for the synthesis of one molecule of PC, and three molecules of S-
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AdoHcy are formed as a result of the reaction. Thus, Hcy is an intermediate amino acid in the 
metabolism of the amino acid Met (21) and a only source of Hcy in mammals is S-AdoHcy 
(22). The concentration of tHcy in plasma can be lowered by enhanced remethylation of Hcy 
into Met or via degradation through the transsulphuration pathway. Folate (5-
methyltetrahydrofolate) or betaine donate a methyl group, while vitamins B12, B6 and 
riboflavin act as cofactors for enzymes involved in the Hcy metabolism (21, 57, 59). Thus, 
Hcy exists at a point of convergence of several B-vitamins, which explains their effects as 
tHcy lowering agents. Betaine is formed in kidney and liver by choline oxidation catalyzed by 
the mitochondrial enzyme, choline dehydrogenase (47, 60, 61). Both PC and betaine 
syntheses are under control of hormones, including sex hormones (estrogen, androgen) and 
insulin.  
 
Predictors of plasma homocysteine, choline and betaine 
Elevated tHcy is observed under a variety of conditions associated with lifestyle and  CVD 
risk factors, e.g. deficiency of B-vitamins (21, 62), cigarette smoking (63, 64), high coffee 
consumption (62, 65) and impaired renal function (66). The role of choline and betaine in 
disease has only more recently been focused upon, and less is known about predictors of 
plasma choline and betaine levels. 
 
Diet 
Homocysteine. Several studies report an association between intake of different nutrients and 
plasma tHcy concentration (21, 62, 67). Two large studies; the Framingham Offspring study 
(n = 1960) and the Dutch population study (n = 2435) have found inverse associations 
between plasma tHcy and intake of folate, vitamin B12, B6, and riboflavin (68, 69). Also, 
mandatory food fortification with folic acid has increased plasma folate and decreased tHcy 
S-AdoMet
Hcy
Met
PC
PE
PC
Cho
P-Cho
CDP-Cho
THF
Protein
PEMT
DMG
Bet
CystaCys
CH3THF
BHMT
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CH2THF
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MS
B12
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B2
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(VLDL)
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FIGURE 1. The methionine and lipid metabolism. 
Phosphatidylcholine (PC) is formed from choline (Cho), which is obtained through the diet, 
or synthesized de-novo from phosphatidylethanolamine (PE). The latter reaction is cata-
lyzed by the S-adenosylmethionine-dependent enzyme, phosphatidylethanolamine N-
methyltransferase (PEMT). PC can also be synthesized via two-step the so-called Ken-
nedy pathway (K-P), where CTP:phosphocholine cytidylyltransferase (CT) is the key regu-
latory enzyme, and phosphor-choline (P-Cho) and cytidine diphosphocholine (CDP-Cho) 
are formed prior to PC. PC is further used for lipoprotein formation (very low density lipid 
[VLDL]). Betaine (Bet) is generated from choline by the sequential action of mitochondrial 
choline dehydrogenase (CD) and betaine aldehyde dehydrogenase (BD). Betaine serves 
as a methyldonor in the betaine-homocysteine methyltransferase (BHMT) reaction, which 
catalyzes the remethylation of homocysteine (Hcy) to methionine (Met); dimethylglycine 
(DMG) is the other product of this reaction. Hcy remethylation is also catalyzed by the 
ubiquitous vitamin B12-dependent enzyme, methionine synthase (MS), which requires 
5-methyltetrahydrofolate (mTHF) as methyl donor.
CK
CT
20a
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concentrations in the general US population (70, 71).  Although less studied, dietary choline 
and betaine have been inversely related to plasma tHcy (62, 72), while there are contradictory 
reports on the relation of protein and methionine to plasma tHcy concentration (62).  
 
The few studies that have examined the associations with total fat, cholesterol, saturated fat, 
mono- and poly-unsaturated fat (73), and omega-3 fatty acids (74) did not find statistically 
significant associations with tHcy concentrations. Results from an Irish study in which dietary 
patterns were related to plasma tHcy concentration, suggested a positive association between 
SFA intake and tHcy (75). The association between plasma tHcy and dietary fish and VLC n-
3 FAs has been studied with inconsistent findings (74, 76-79). It has been hypothesized that 
high intake of n-3 fatty acids may reduce tHcy but only in combination with a high B-vitamin 
intake (12). There are even fewer studies of other dietary fat types. One study found that 
consumers of skim milk had lower plasma tHcy concentrations than non-consumers (80), 
suggesting an positive association between saturated fat intake and plasma tHcy.  
 
Studies have shown that tHcy concentration is inversely related to the intake of food groups 
such as bread (67), cereal (73, 81), fruit (67, 82), vegetables (67, 74, 82), and to individual 
food items including cruciferous vegetables (81, 82), peppers (81), citrus fruits and juices (67, 
82), cold breakfast cereals (73, 81, 82), milk (73, 81), yoghurt (81), and liver (67). Positive 
associations have been found with caffeine-containing drinks such as coffee (62, 69), Coca 
Cola (69) and tea (62, 69), while findings on alcohol are conflicting (67, 69).  
 
Studies that have investigated associations between plasma tHcy levels and dietary patterns 
(83-87) have found that a Western type dietary pattern, characterized by high consumption of 
products high in fat and sugar, is related to higher tHcy levels (84, 86, 87), while a diet high 
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in folate and B-vitamins is associated with lower tHcy concentrations (83-85). 
 
Choline and betaine. Choline and betaine may be obtained from the diet. Choline, the major 
source of methyl groups in the diet, is found in eggs, beef, pork, liver, soybean and wheat 
germ, whereas foods with the highest content of betaine are wheat bran, wheat germ and 
spinach (47, 88).  
 
Several studies have found inverse associations between dietary choline and betaine and 
plasma tHcy level (72), and supplementation with choline and betaine has been shown to 
reduce tHcy concentration (29, 38). However, the mechanism through which dietary choline 
and betaine may affect plasma tHcy is not known. The relation between dietary choline and 
betaine and plasma levels of respectively choline and betaine, has not been investigated in 
epidemiological studies. Also, the relations of plasma choline and betaine to dietary patterns 
or intake of individual foods and beverages have not been investigated. 
 
CVD risk factors 
Homocysteine. Plasma tHcy shows a positive relation to a variety of CVD risk factors (5, 89). 
tHcy concentrations increase by age, and are higher in men than women (4). It is increased 
under condition of impaired renal function  (21, 90) and is positively related to plasma 
creatinine (66). Recent studies have demonstrated that plasma tHcy increases with the number 
of components of the metabolic syndrome (91, 92), which refers to the cluster of risk factors 
related to central obesity, including elevated blood glucose, dyslipidemia and hypertension 
(93).  
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Choline and betaine. Little is known about the relation of CVD risk factors to choline and 
betaine. In postmenopausal women, dietary intake of betaine and choline was found not to be 
associated with CVD risk (33), while dietary intake of choline and betaine in healthy adults 
was associated with decreased concentrations of inflammatory markers (94). In a study 
among patients attending a lipid clinic, betaine was inversely associated with body fat and 
Apo B (44).  
 
Rationale for the present study 
Elevated tHcy is associated with an increased risk for hospitalisations due to CVD (95) and 
increased risk for death (4, 96). Randomized clinical trials have not found a risk reduction by 
tHcy lowering therapy with high-doses of B-vitamins in patients with established CVD (22-
24). A relation between tHcy and dietary habits in community-dwelling adults and elderly 
have previously been investigated only in a few studies (97). We therefore wanted to study 
the effect of diet on plasma tHcy level in a large population-based study of more than 5800 
men and women aged 47-49 and 71-74 y, in Norway where food is not fortified with B-
vitamins. To understand the associations between plasma tHcy concentration and foods with 
high and low B-vitamin content, we included major food groups and individual food items in 
our study. Moreover, we examined the association between dietary intake of folate, vitamin 
BB12, B6, riboflavin and other nutrients and plasma concentration of tHcy. We included 
nutrients other than B-vitamins to examine whether these might have an additional effect on 
tHcy concentration. This latter was possible because our dietary data allowed us to 
quantitatively assess the possible confounding effect of B-vitamins.  
 
The association between fat intake and plasma tHcy has not been previously studied in a large 
population-based study. In the present study we addressed the question whether dietary fat 
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and especially VLC n-3 FA, mainly present in fish and marine oils, are associated with tHcy 
concentrations. Because there is experimental evidence that PC synthesis via the PEMT 
pathway can be increased by dietary fat (98), we hypothesized that the intake of different fat 
types may have different effects on PC synthesis and further on plasma tHcy concentration.  
 
The role of plasma choline and betaine in cardiovascular disease is not well known, nor is the 
association of CVD risk factors, including diet, with plasma concentrations of these two 
metabolites known. The Hordaland Health Study afforded the examination of plasma choline 
and betaine in relation to individual foods, beverages, nutrients, and dietary patterns, as well 
as to CVD risk factors including several components of the metabolic syndrome. 
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2    AIMS OF THE STUDY 
This dissertation addresses the epidemiology of nutrition and other CVD risk factors in 
relation to components of one-carbon metabolism, i.e. homocysteine, choline and betaine, in 
middle age (47-49 y) and elderly (71-74 y) men and women in a large population-based study 
in Norway. 
The specific aims were to: 
1. Assess the relationship between nutrients and food intake on plasma concentration of 
tHcy  
2. Evaluate the association of dietary fat and especially VLC n-3 FAs with plasma tHcy 
concentration  
3. Describe the population distribution of plasma choline and betaine concentrations  
4. Assess the relations between individual dietary factors (foods, beverages and 
nutrients) and major dietary patterns on plasma choline and betaine  
5. Investigate the association of plasma choline and betaine with CVD risk factors, 
including components of the metabolic syndrome  
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3    STUDY POPULATION AND METHODS 
Study population 
The Hordaland Health Study (HUSK) was conducted from 1997 to 1999 as a collaboration 
between the National Health Screening Service (now the Norwegian Institute of Public 
Health), the University of Bergen, the University of Oslo and local health services in the 
Bergen area. Among those invited were subjects who had previously participated in the 
Hordaland Homocysteine Study (HHS I) during 1992-93, and who were born 1925-27 and 
1950-51. This second round of the Hordaland Homocysteine Study is referred to as HHS II, 
and participants here comprise the study population in the articles included here. Of the total 
sample of 9187 men and women who were invited to participate in HUSK, 7074 (77%) 
agreed to participate. The participants underwent a brief health examination and donated a 
nonfasting blood sample. Information on diet and lifestyle was collected via self-administered 
questionnaires. In total 6145 subjects (87%) completed a food frequency questionnaire (FFQ); 
among these, plasma tHcy was measured in 6118 and plasma choline and betaine in 6112 
(Table 1).
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TABLE 1.  
Description of exclusion criteria of participants included in the four articles comprising 
this dissertation 
 
Article/Study 
 
 
 1 2 3 4 
 
Participants in HUSK
 
7074 
 
7074 
 
7074 
 
7074 
  Plasma tHcy measured 7053 7049 7045 7045 
  Plasma choline and betaine measured   7045 7045 
  Completed nutritional form 6145 6145 6145 6145 
Number of participants excluded: 
  Missing information of vitamin use 
 
5 
 
5 
  
  Missing information of plasma tHcy 22 22   
  Missing information of plasma choline 
  and betaine 
  29 29 
  Missing information on dietary fatty acids   4  
Sample without missing information 6118 6118 6112 7045 
  Exclusion for energy intake*  301 201 300  
Remaining sample, n 
                               % 
5812  
82.2 
5917 
83.6 
5812 
82.2 
7045 
99.6 
* in study 1 and 3: below 2.5 percentile (2124 kJ for women 71-74 y and 3899 kJ for 
women 47-49 y; 3856 kJ for men 71-74 y and 5572 kJ for men 47-49 y) and above 
the 97.5 percentile (11098 kJ for women 71-74 y and 12970 kJ for women 47-49 y; 
14023 kJ for men 71-74 y and 17590 kJ for men 47-49 y); in study 2 < 3000 kJ for 
women; < 3300 kJ for men and >15000 kJ for women; > 17500 kJ for men.  
 
 28
Study 1 
We excluded participants with missing values for plasma tHcy (n = 22), dietary data (n = 933) 
and those with reported energy intake below the 2.5 percentile and above the 97.5 percentile. 
By these latter criteria, 141 men and 187 women were excluded, yielding a final number of 
5812 participants (82% of those attending the health examination). Participants with reported 
seasonal or regular intake of at least one dose of a multi- and/or individual vitamin 
supplement (excluding fish oil and omega 3 fatty acids) per day were assigned to the vitamin 
supplement user group (n = 1234). Thus, the group of non-users of vitamins consists of 4578 
individuals (65% of participating subjects). 
 
Study 2 
After excluding individuals with missing plasma tHcy values (n = 25) and dietary data (n = 
933), participant with a very low and very high estimated daily energy intake, which left 5917 
individuals (83.6% of those attending the health examination). 
 
Study 3 
In addition to excluding participants with missing values for plasma choline and betaine (n = 
29) and nutritional data (n = 933) we excluded participants with reported energy intake below 
the 2.5 percentile and above the 97.5 percentile. By these latter criteria, 131 men and 169 
women were excluded from the analyses, yielding a final number of 5812 (82% of 
participants). 
 
Study 4 
We excluded 29 persons with missing value for choline and betaine concentrations, thus the 
final number of participants was 7045 (99.6% of 7074).  
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Health survey  
The health examination included measurements of height and weight, as well as waist and hip 
circumferences, following standard protocols used by the National Health Screening Service. 
Blood pressure was measured after 10 min seated resting using Dinamap 845 XT equipment 
(Criticon, Tampa, Fla), and the mean values of three measurements were used for analyses. 
Body composition including percent body fat was measured by dual energy x-ray 
densitometry (EXPERT-XL; Lunar Company Inc, Madison, Wis) (99). Level of physical 
activity was defined as a combination of intensity and frequency: no, low, moderate and high 
activity. Smoking status was defined as ‘current smokers’ and ‘non-smokers (including 
former smokers)’ in study 2, 3 and 4, while we used three groups ‘current smokers’, ‘former 
smoker’ and ‘non-smokers’ in study 1. At the time of the blood draw, time since last meal 
was recorded (from 0 to 11 hours). 
 
Assessment of diet 
Dietary data were collected by using a 169-item FFQ, a slightly modified version of a FFQ 
previously described in detail (100). This FFQ aimed to capture the habitual diet during the 
past year and included frequency alternatives (from once a month to several times per day), 
the number of portion eaten and portion sizes (e.g. slices, glasses, cups, pieces, spoons).  
 
The information from the FFQ is presented as individual food items, food groups (consisting 
of several individual food items) and nutrients. Individual food items correspond to the items 
listed on the questionnaire, whereas ‘food groups’ include related food items. The FFQ also 
included nine questions about vitamin supplements on the market at the time of the study. 
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Subjects using at least one dose of vitamin supplement per day seasonally or regularly during 
the past year were classified as vitamin supplement users.  
 
Daily nutrient intake was computed from a database and software system developed at the 
Department of Nutrition, University of Oslo (Kostberegnings-SYSTEM, version 3.2). The 
nutrient database was mainly based on the official Norwegian food composition table with an 
update on folate content from 2001 (101). B-vitamin intake in supplements was calculated 
from information on the contents of vitamin supplements for sale during 1997-99. We 
assessed daily consumption of the main food groups and items contributing to the intake of 
major macro- and micro-nutrients, including vitamins (folate, vitamins B12 and B6, riboflavin, 
thiamine, α-tocopherol, β-carotene, retinol equivalents, vitamins D and C), and different types 
of fat (saturated fatty acids [SFA], monounsaturated fatty acids [MUFA], and the 
polyunsaturated fatty acids [PUFA], n-6 PUFA, n-3 PUFA and VLC n-3 PUFA). For the 
dietary pattern anlysis we assigned each food item into one of 41 non-overlapping food 
groups (Table 2). 
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TABLE 2.  
Definition of food groups from the food frequency questionnaire items 
 
Food groups 
 
FFQ items contributing to food group 
Refined bread  
Medium-fiber bread  
High-fiber bread  
Breakfast cereals Oat, rice flakes, mixture of cereals, porridge, MUSLI 
Flour, rice, pasta Wheat, rye, oat, wheat germ, rice, pasta 
Pizza With and without meat 
Cakes Cakes, cookies, wafflers, Danish 
Potatoes Boiled, baked, fried, pommes frites 
Carrots  
Cabbage, kohlrabi  
Cauliflower, broccoli Brussel sprouts 
Onions, spinach Garlic, parsley 
Cucumber, tomato, pepper, 
lettuce 
 
Vegetables, raw other  
Vegetables mixed, frozen and 
preserved 
 
Mushrooms  
Beans, peas, dried  
Fruit  Fruits and berries, fresh, dried or canned with sugar 
Juice From fruits and berries 
Red meat, whole Beef, pork, lamb, game meat, minced meat 
Processed meat Sausages, meat balls, meat puddings, other meat 
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products 
Liver Liver paté 
Chicken  
Eggs  
Lean fish Cod, saithe, haddock, catfish, pollack  
Fatty fish Salmon, trout, herring, mackerel, halibut 
Processed fish Fish balls, fish pudding, other fish products  
Shellfish Shrimp, crab, mussels, roe, fish liver  
Milk  Whole and reduced fat, sour milk (kefir) 
Yoghurt Whole and reduced fat and sugar, yoghurt with fruits 
Cheese White cheese, cottage cheese, blue cheese, goats 
cheese, other cheese, brown (whey) cheese 
Cream, ice cream Sour cream, whipping cream, milk desserts, pudding 
Margarine, butter High, reduced and low fat, soya 
Oils  Vegetable, cooking, olive, maize, soy, sunflower,  
Mayonnaise High and low fat dressing 
Sugar, sweets Diet sugar, chocolate, honey, candy, other sugar 
products 
Snacks Popcorn, potato chips nachos, nuts, other snacks 
Coffee  
Tea  
Soft drinks with sugar Soda with sugar and diet soda 
Alcoholic beverages Beer, wine, liquor 
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Analytic procedures 
Non-fasting blood samples used for the preparation of plasma were collected into evacuated 
tubes containing EDTA, placed in a refrigerator (4-5°C) within 15-30 minutes, and 
centrifuged, usually within 1 hour (maximum within 3 hours). EDTA plasma was stored at -
80° C. For study 1 and 2 plasma tHcy was determined by automated HPLC with fluorescence 
detection. Intra-assay coefficient of variation was 3% (102). For study 3 and 4 plasma 
choline, betaine, tHcy and creatinine were determined by a method based on normal-phase 
chromatography-tandem mass spectrometry (LC-MS/MS) (103). For these two studies we 
used the new measurement values for tHcy and creatinine because they were included in the 
new platform and were measured at the same time as choline and betaine. The concentration 
of plasma folate was measured by a Lactobacillus casei microbiological assay (104) and 
plasma vitamin B12 concentration by a Lactobacillus leichmannii microbiological assay 
(105). 
 
Blood samples used for the preparation of serum were collected into evacuated tubes 
containing sodium sulphite titration gel and centrifuged within two hours. The serum tubes 
were transported to the department of Clinical Chemistry, Ullevål University hospital, Oslo, 
where determination of glucose, total cholesterol, HDL cholesterol and triglycerides were 
performed, using enzymatic methods with reagents from Boehringer Mannheim, Federal 
republic of Germany as adapted to a Hitachi 911 analyzer. HDL cholesterol was measured by 
a direct, enzymatic inhibition method. Serum lipids were determined within seven days after 
collection of the sample. The concentration of serum creatinine was measured with standard 
alkaline picrate colorimetric assay.  
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Statistical methods 
Several statistical methods were used for data analyses in the study. Descriptive methods 
were used to evaluate differences between population groups: men and women (study 1, 2, 3, 
4), older and younger individuals (study 1, 2, 3, 4), vitamin supplements users and non-users 
(study 1). Spearman partial correlations were used to assess the relationship between dietary 
and plasma B-vitamins with foods and nutrients (study 1). The same method was used to 
evaluate the association between plasma choline and betaine (study 4). Multiple linear 
regression analyses were used to assess the effect of independent variables on the outcome 
variable (study 1, 2, 3, 4) and to evaluate possible interaction effects (study 1, 2). In addition, 
linear and logistic regression (study 1, 2) was used for comparing differences between study 
groups. The Gaussian generalized additive regression models (GAM) were used to assess 
dose-response relations between study and outcome variables (study 2). To define major 
dietary patterns principal component analysis (PCA) was used prior to factor analysis (study 
3). PCA allows reduction of the number of study variables to principal components (factors) 
(106). Three factors were extracted to produse three dietary patterns which were used in 
futher analyses.  
 
In general several adjustment models were used to control for possible confounding. The first 
model was adjusted for age and gender (study 4) and energy intake (study 1, 2, 3). Second 
and third models included additional adjustments for smoking, coffee consumption, physical 
activity, BMI, intake of fruits and vegetables, dietary or/and plasma B-vitamins, time since 
last meal and plasma/serum creatinine.  
 
All statistical analyses in study 1, 3 and 4 were performed using SAS for Windows v 9.1 
(SAS Institute Inc., Cary, NC, USA). In study 2, we used SPSS for WINDOWS software, 
 35
release 12.0.1; SPSS Inc., Chicago, IL). Gaussian generalized additive regression models (30) 
was implemented in S-PLUS for WINDOWS (version 6.2; Insightful Corporation, Seattle, 
WA). In addition, we used augmented convex hull plots as implemented in the programme 
“R” for graphical presentation of choline and betaine distributions in study 4 (107).  
 
We initially conducted all analyses stratified by the four age and sex groups. Differences in 
the consumption of food groups and nutrients between age groups and sex and between users 
and non-users of vitamin supplements were assessed by linear regression for continuous 
variables and logistic regression for categorical variables. In study 2 potential differences in 
tHcy, BMI and dietary factors between gender and age groups were tested by univariate 
analysis of variance and logistic regression. In study 3, differences in plasma choline, betaine, 
creatinine, BMI, foods and nutrients were assessed by Wilcoxon rank sum tests. In study 4, 
we used independent sample t-tests for assessing differences in plasma choline and betaine 
between sexes and age groups. 
 
In multiple linear regression analyses, the continuous predictor and covariate variables were 
categorized in quartiles, except time since last meal, and with the exception of some variables 
(foods and beverages) for which a high proportion of the subjects (more than 50% of 
participants) reported ‘no use’. For these variables three categories were used: ‘non-users’ 
and two equally large groups of users. Thus, the regression coefficients estimated the mean 
(95% CI) differences in plasma tHcy, choline and betaine concentrations per increasing 
quartile or contrasting group of the predictor variables (foods, beverages, nutrients, dietary 
pattern scores, lifestyle factors, body composition, blood pressure, serum lipids and glucose, 
plasma folate, vitamin B12, tHcy and creatinine). All P values were 2-sided and values < 0.05 
were considered significant. Categories of predictors were defined separately for each of the 
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four age-sex groups, two age groups and users and non-users of vitamin supplements. Results 
were combined for the two age groups and for men and women in study 1 and 3, because the 
observed trends were similar in all the four age-sex groups. 
 
In the first study, we found an interaction effect of vitamin user group on the associations 
with several food groups and nutrients. Thus, due to these results and the fact that B-vitamin 
supplementation may substantially reduce plasma tHcy concentration and therefore mask the 
effects of dietary components, we restricted the study sample to non-users of vitamin 
supplements in further in-depth analyses.   
 
In the second study, for the association between tHcy and dietary factors in the two age 
groups, we used multiple linear regression analysis to estimate the least squares mean of tHcy 
concentrations by categories of dietary factors. tHcy values were log10 transformed, and back 
transformed means and 95% confidence intervals are presented. Because we observed several 
significant interactions by age group, but not by sex, results are presented for the whole 
group, as well as for the two age groups.  
 
For testing of the interaction between B-vitamins and n-3 FA intake, we constructed a 
summary score for total B-vitamin intake, which was calculated as the sum of quartile scores 
(1-4) for intake of folate and riboflavin and vitamins B6 and B12. Interaction between the 
quartiles of total B vitamin intake and the intake of these FAs was analyzed by multiple 
regression, which included a product term of the quartile of n-3 FA or VLC n-3 FA intake and 
the total B-vitamin intake score. We also evaluated the intakes of n-3 and VLC n-3 FAs as 
tHcy predictors in strata of B-vitamin intake by carrying out multiple regression analyses in 
the separate quartiles of B-vitamin intake. 
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Gaussian generalized additive regression models (108) were used to generate graphic 
representations of the dose–response relations between tHcy concentrations and the intake of 
different types of fat.  
 
Three factors (dietary patterns) were extracted using PCA based on eigenvalues > 2, the scree 
plot and the natural interpretation of the factors after orthogonal (Varimax) rotation. The 
derived factors were labelled on the basis of knowledge of Norwegian dietary habits and 
nutritional science as “Western”, “Healthy” and “Traditional”. The factor score for each 
pattern was calculated by summing intakes of food groups weighted by their factor loadings, 
and each participant received a factor score for each identified pattern. We categorised 
participants by quartiles of dietary pattern scores. Mean differences in plasma choline and 
betaine per increasing quartiles of the three defined dietary pattern scores were calculated in 
linear regression analyses. 
 
Approvals 
The study protocol was approved by the Regional Committee for Medical Research Ethics 
and the Norwegian Data Inspectorate. All subjects gave their written consent to participate in 
the study. 
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4    SUMMARY OF RESULTS 
 
Major dietary predictors of plasma tHcy  
Plasma homocysteine in users and non-users of vitamin supplement.  
The first study aimed to assess dietary predictors of plasma tHcy in a Norwegian population 
sample. It is important for this study question to note that food is not fortified with B-vitamins 
in Norway. Because vitamin use and lifestyle in general may have complementary effects on 
tHcy level, we first investigated differences between users and non-users of vitamin 
supplements and secondly, differences in associations between tHcy and dietary predictors in 
these two groups. Approximately 21% of participants reported the use of vitamin supplements 
(not including fish and fish liver oils). Compared to non-users, there was a higher proportion 
of women among users of vitamin supplements (P < 0.0001). Moreover, supplement users 
had a lower proportion of smokers, lower BMI and coffee consumption, and higher intakes of 
cereals, fruits, vegetables and fish compared to non-users. The intake of vitamins from the 
diet, including B-vitamins, was also higher in users compared to non-users of vitamin 
supplements. The former group also had lower concentrations of tHcy (P < 0.0001), whereas 
plasma folate and vitamin B12 were higher (P < 0.0001 and P < 0.02, respectively).  
 
In addition, there were differences in the associations between food groups and nutrients with 
plasma tHcy between users and non-users of vitamin supplements. Therefore, users of vitamin 
supplements were excluded from further analyses. In non-users of vitamin supplements, 
plasma tHcy was more strongly predicted by plasma folate (r=- 0.37) and vitamin B12 (r=- 
0.22), compared to dietary intake of folate (r=- 0.15), vitamin B12 (r=- 0.07), B6 (r=- 0.14) 
and riboflavin (r=- 0.12). Dietary folate was significantly positively correlated with the intake 
of vegetables, fruits and fiber, as well as with most other vitamins, including vitamin B6 
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(r=0.56), riboflavin (r=0.37), and vitamin B12 (r=0.16). On the other hand, intake of simple 
carbohydrates was inversely associated with dietary folate, B6 and riboflavin. In addition, 
consumption of fat was inversely related to the dietary folate, B6 and riboflavin, and to 
plasma folate (r=- 0.33).  
 
Plasma homocysteine according food groups, food items and nutrient  
Plasma tHcy was associated with several different nutrients and foods. Plasma tHcy level was 
lower not only with increased consumption of plant-origin food, vegetables, fruits and cereals, 
but also with intake of eggs, fish and milk, chicken and non-processed meats. The estimated 
mean difference in tHcy per increasing quartile of intake ranged from - 0.11 (95% CI - 0.21, - 
0.01) μmol/l for milk to - 0.32 (- 0.42, - 0.22) μmol/l for vegetables. Furthermore, individual 
food items such as citrus fruits, orange juice, cruciferous vegetables, and spinach/green 
cabbage were related to lower plasma tHcy levels. Whole grain (medium- and high-fiber) 
bread had an additional inverse, but weaker effect on plasma tHcy level, while sugar products 
and cakes were positively related to tHcy concentration. Among nutrients, complex 
carbohydrates, protein and B vitamins (folate, vitamin B12, B6 and riboflavin) were 
associated with lower tHcy concentrations, while the intake of fat and sugar were associated 
with increased plasma tHcy.  
 
Plasma homocysteine according to type of dietary fat 
Plasma tHcy concentrations was inversely related to the consumption of lean fish, reduced fat 
milk, skim milk, vegetable oil and fish oil supplement. The magnitude of the differences in 
tHcy between the highest and the lowest quartile of intake of these foods ranged from 2.5% to 
6.3 %. On the other hand, plasma tHcy concentration was positively associated with the 
consumption of total fat (P for trend from lowest to highest quartiles < 0.001), SFAs (P for 
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trend < 0.001), MUFAs (P for trend < 0.005) and PUFAs (P for trend = 0.03; significant only 
in the youngest age group). The difference in tHcy between the highest and the lowest 
quartiles of SFAs was 8.8%. In contrast, the intake of marine VLC n-3 FAs was inversely 
associated with tHcy level, the difference in tHcy between the highest and the lowest quartiles 
was – 5.0% (P for trend < 0.001).  
 
The association between SFAs and plasma tHcy was independent of the effects of dietary 
folate and other B-vitamins (P < 0.001). However, there was an interaction between total 
intake of B vitamins (folate, B6, B12 and riboflavin) and the total intake of n-3 FAs, as well as 
VLC n-3 FAs (P=0.01) with plasma tHcy concentrations. When stratified by quartiles of B-
vitamin intake, the inverse trend between tHcy and VLC n-3 FAs intake was significant only 
in the highest quartile of B-vitamin intake. This was also observed when excluding users of 
fish-oil and B-vitamin supplements.  
 
Major predictors of plasma choline and betaine 
Plasma choline and betaine according age group and sex 
Overall, plasma concentrations (mean±SD) of betaine were four times higher compared to 
plasma free choline 39.5±12.5 µmol/L versus 9.9±2.3 µmol/L, respectively. Plasma choline 
and betaine were positively correlated (r=0.37; P < 0.0001). Both choline and betaine were 
lower in women than in men, and in younger subjects compared to older (P < 0.0001).  
 
Plasma choline and betaine according foods, beverages and nutrients 
Levels of both choline and betaine were decreased with increasing time since the last meal. 
Plasma choline was positively associated with the consumption of individual food items such 
as eggs, skim milk and beer, and inversely related to legumes, coffee and sugar products. 
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Choline was not significantly associated with total energy intake, and the only nutrient 
associated with choline was cholesterol. 
 
Plasma betaine was positively associated with intake of high-fiber bread and tea, and 
inversely related to non-processed meat, shellfish, whole milk, cream, butter, mayonnaise, 
sugar products, soft drinks and alcoholic beverages (except beer). It was also positively 
related to energy intake. With regard to nutrients, betaine was positively related to complex 
carbohydrates, fibers, folate and thiamine, and inversely associated with total, saturated and 
monounsaturated fat, as well as with alcohol.  
 
Plasma choline and betaine according to dietary patterns 
Three major dietary patterns were identified by factor analysis and denoted “Western”, 
“Healthy” and “Traditional”. Plasma choline was not significantly associated with any of 
these patterns, while betaine was inversely related to the “Western” dietary pattern, 
characterized by high loadings for pizza, pasta, meat, products high in fat and sugar including 
soft drinks, and alcoholic beverages (P < 0.0001). Controlling for potential confounders, such 
as smoking, physical activity and BMI did not materially change the association (P = 0.0001). 
 
Plasma choline and betaine according components of the metabolic syndrome  
Similarly to the findings of different associations between choline, betaine and diet, choline 
and betaine also showed divergent association with key components of the metabolic 
syndrome. Choline was positively associated with serum TGs, glucose, BMI, percent body fat 
and waist circumference (P < 0.0001 for all), and inversely related to HDL cholesterol (P < 
0.05). On the other hand, betaine was inversely associated with serum non-HDL cholesterol, 
TGs, BMI, percent body fat, waist circumference, systolic and diastolic blood pressure (P < 
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0.0001 for all), and positively associated with HDL cholesterol (P < 0.01). Thus, an 
unfavourable cardiovascular risk factor profile was associated with high choline and low 
betaine concentrations. The associations were similar in the four sex-age groups, except for 
the positive relations of choline to BMI, percent body fat, and waist circumference, which 
were significant only among women, although a similar trend was seen also among men.  
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5    DISCUSSION 
The basic aims of this dissertation were to examine plasma homocysteine, choline and betaine 
in relation to diet and other CVD risk factors. Dietary variables examined were food groups, 
food items and beverages, nutrients and dietary patterns. Moreover, because the distribution 
of plasma choline and betaine in the general population is not known, we also wished to 
examine this. The relation of plasma choline and betaine to smoking, physical activity, body 
mass index, percent body fat, waist circumference, blood pressure, serum lipids and glucose 
was also examined. Methodological strengths and limitations and to what extent bias and 
confounding may have influenced the results will be discussed. This is the largest 
observational study on diet as predictor of plasma tHcy, choline and betaine in a general 
population sample in a country in which food is not fortified with B-vitamins. It is also the 
first study of the relation of dietary patterns to plasma choline and betaine, and the largest 
study ever examining associations between major components of the metabolic syndrome and 
plasma choline and betaine. 
 
Methodological considerations 
In this section internal and external validity of the study will be discussed. The internal 
validity deals with the rigour of the theoretical, methodological and empirical bases 
underlying the research project (109, 110). In our study internal validity deals with the degree 
to which investigated relations and effects of exposure (diet, lifestyle and other CVD factors) 
on outcome measure (plasma tHcy, choline and betaine concentrations) is true for the study 
population. The possibility of confounding and bias will be discussed because of their 
potential effects on the findings. ‘The external validity reflects the relevance and accessibility 
to user groups outside the study population’ (109, 110), and refers to the degree to which 
results of the study may be extrapolated to the general population, also called generalizability. 
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Study design 
Our studies were observational with a cross-sectional design. Exposure and outcome variables 
were measured approximately at the same time, thus inferences regarding cause and effect 
may not be drawn. In an ideal cross-sectional study, the study sample should reflect various 
health status and social-demographic groups in proportions distributed in the source 
population, location and time. The cross-sectional design with a reasonable high participation 
rate allows assessment of the prevalence of diseases and risk factors in a given population.  
 
Selection bias 
Selection bias may be introduced from procedures used to select individuals for the study and 
from factors influencing study participation. The relations between the exposure and outcome 
therefore may be different for the participating individuals and for individuals eligible for the 
study, but who do not participate. 
 
All 9187 non-institutionalized persons from four communities in Hordaland County born 
1925-27 and 1950-51 were invited to the second round of the Hordaland Homocysteine Study 
in 1997-99, as part of the Hordaland Health Study (HUSK). Thus, the study population was 
large and well defined. Analyses of a few socio-demographic characteristics for attendees and 
non-attendees in HUSK has been reported: 
http://www.uib.no/isf/husk/Vedlegg_dokumenter/FrafallsanalyseHUSK9799.pdf. However, 
these comparisons are for the HUSK study population as a whole, with no information 
specifically for the age groups included in this study.   
 
Analysis of socio-demographic and other characteristics of HUSK participants who did and 
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did not fill out the FFQ showed that among those who did complete the questionnaire (the 
nutrition substudy group) there was a higher proportion of men in the oldest group, and a 
lower proportion men in the youngest group (Tables 3 and 4). Compared to those who did 
not complete the FFQ, a smaller proportion of the nutrition substudy group were smokers and 
physically inactive, and a smaller proportion had diabetes. In the youngest group, a larger 
proportion of the nutrition substudy participants had used medications the day before the 
survey. In the oldest group, the nutrition substudy participants consumed more alcohol and a 
smaller proportion had not completed high school. Thus, the HUSK participants who took 
part in the nutrition substudy had generally a healthier lifestyle compared to those who did 
not. 
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TABLE 3. Comparison between 71-74 year-old participants and non-participants in the 
nutritional substudy based on data from the Hordaland Health Study (HUSK 1997-99). 
 
Selected variables 
Participants  
N = 3017 
% 
Non- 
participants 
N = 330 
% 
 
p-value* 
Men 44.7 39.1    0.05 
BMI > 30 kg/m2 13.4 18.2    0.03 
Systolic blood pressure > 130 
mmHg 
80.8 78.5    0.30 
Daily smoker 15.2 21.4    0.004 
No and low physical activity** 37.5 47.9    0.0002 
Alcohol > 5 times/month 14.5   6.1 < 0.0001 
Coffee > 5 cups/d   8.1   7.3    0.59 
Self defined health status as good 
and very good 
14.4   9.2    0.19 
Myocardial infarction 10.0   9.3    0.71 
Diabetes mellitus   6.4 10.3    0.009 
Angina pectoris 11.8   9.4    0.20 
Stroke   4.3   6.6    0.06 
Medicine use, yesterday 76.9 78.9    0.45 
Did not complete high school 45.6 62.7    0.01 
* evaluated by Chi-square test 
** < 2 hours/week of non-intensive or < 1 hour/week of intensive physical activity.
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TABLE 4. Comparison between 47-49 year-old participants and non-participants in the 
nutritional substudy based on data from the Hordaland Health Study (HUSK 1997-99). 
 
Selected variables 
Participants  
N = 3121 
% 
Non- 
participants 
N = 615 
% 
 
p-value* 
Men 43.0 52.4 < 0.0001 
BMI > 30 kg/m2 10.4 11.4    0.46 
Systolic blood pressure > 130 
mmHg 
40.6 44.2    0.10 
Daily smoker 33.8 39.2    0.01 
No and low physical activity** 24.8 31.4    0.0007 
Alcohol > 5 times/month 30.1 27.8    0.26 
Coffee > 5 cups/d 20.2 22.4    0.20 
Self defined health status as good 
and very good 
43.6 34.8    0.08 
Myocardial infarction   0.6   0.8    0.42 
Diabetes mellitus   0.8   2.0    0.008 
Angina pectoris   0.9   1.0    0.85 
Stroke   0.6   0.5    0.79 
Medicine use, yesterday 53.0 46.0    0.002 
Did not complete high school   6.1   7.0    0.80 
Annual income < 200.000 NOK 22.0 22.8    0.66 
* evaluated by Chi-square test 
** < 2 hours/week of non-intensive or < 1 hour/week of intensive physical activity. 
 Information bias 
Incorrect information about exposure variables collected from participants may cause 
systematic error in the estimated relations. Information bias includes measurement errors and 
may cause misclassification. When misclassification is related to the exposure variable then 
associations between exposure and outcome may be strengthened or weakened by 
misclassification. On the other hand, when misclassification is not related to exposure or 
outcome, it has attenuating effect on the relation between exposure and outcome. 
 
Food frequency questionnaire. The FFQ is a self-administered questionnaire which has a 
potential for misclassification of dietary intake (111, 112). This FFQ was developed to 
estimate the habitual diet during the past year. It has less sensitivity, but higher specificity, 
compared to 24-hour dietary recall and dietary diary methods (112). However, it is quick, 
informative and relatively inexpensive to use in epidemiological studies. The FFQ includes 
frequency alternatives (from once a month to several times per day), the number of portion 
eaten and portion sizes (e.g. slices, glasses, cups, pieces, spoons). Therefore, the estimated 
total energy consumption may depend on the participants’ ability to remember what they have 
eaten over the past year. In addition, participants’ willingness to report about their real dietary 
consumption is also important. For example, obese individuals often under-report their total 
and individual food consumption (113).  
 
Daily nutrient intakes were computed from a database and software system developed at the 
Department of Nutrition, University of Oslo (Kostberegnings-SYSTEM, version 3.2). This 
database also has potential misclassifications in estimation of nutrient intakes merely due to 
changes in the contents of food and beverages over time. For example, vitamin content of 
fruit and vegetables may vary according to season, and contents of ‘ready to eat’ foods may 
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vary between producers. Moreover, the preparation of food including cooking methods may 
impact the nutrient content in foods, folate and riboflavin, for example, are susceptible to 
losses during cooking (114, 115). In addition, our database could not comprehensively assess 
the impact of vitamin supplement use, which could lead to systematic misclassification of 
total vitamin consumption. 
 
Blood samples.  No instructions were given to participants regarding fasting status before the 
blood draw, thus most participants were not fasting. Concentrations of plasma tHcy, choline 
and betaine may be affected by prandial status and reflect recent dietary intake (103, 116). 
Moderate increase in plasma choline and betaine was observed 2-3 hours after a meal (103). 
We found that plasma choline and betaine were gradually lower with increasing time since 
last meal (from 1 to 11 hours), while tHcy was higher, as reported previously (116). However, 
the decreased concentrations of plasma choline and betaine and the increased level of tHcy 
may probably not affect the study associations.  
 
One may argue that non-fasting blood samples with accompanying postprandial increases in 
blood glucose and triglycerides may attenuate the observed relations with choline and betaine. 
This could be possible due to moderate increase of choline and betaine for 2-3 hours after a 
meal (103), as was discussed above. However, recent studies suggest that postprandial TG 
values may be a stronger predictor of CVD risk than fasting levels (117). In addition, we 
determined non-HDL cholesterol, which is reliable in non-fasting serum and may be used for 
risk assessment instead of TG and LDL levels, as was suggested by the Third Report of the 
National Cholesterol Educational Program (NCEP) Adult Treatment Panel III (118). 
 
The influence of factors known to affect plasma tHcy concentration was minimized during 
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sample collection and storage, by following a strict procedure. Samples (EDTA plasma) were 
stored at -80° C before analyses. The delay before analyses may have lead to an artificial 
increase in plasma tHcy concentration by 0.5µmol/L due to additional release of 
homocysteine from blood cells (102). This release may increase the low values of tHcy and 
reduce the difference between the highest and the lowest tHcy levels. Thus, tHcy release from 
blood cells has a propensity to attenuate the effect of tHcy on choline and betaine, as well as 
on CVD risk factors (119).  
 
In study 1 and 2 we used data on plasma tHcy which was determined by automated HPLC 
with fluorescence detection. This method has high sensitivity for detection of tHcy. Intra-
assay coefficient of variation was 3% (102). However, because a new analytical procedure 
based on normal-phase chromatography-tandem mass spectrometry (LC-MS/MS) was 
developed for detection of choline, betaine and several other metabolites, in study 4 we 
therefore used data on tHcy and creatinine assessed by this method (103). The tHcy values 
measured by the two methods were highly correlated.  
 
Blood pressure, smoking and physical activity.  To get a more stable data on blood pressure, it 
was measured after 10 min seated resting using Dinamap 845 XT equipment (Criticon, 
Tampa, Fla) three times and the mean values of three measurements were used for analyses. 
Because data on smoking and physical activity were collected via self-administered 
questionnaire, it may lead to misclassifications in estimation of prevalence and intensity of 
daily smoking and physical activity and systematic errors in our papers. Underestimation of 
smoking may lead to underestimation of its effect on tHcy, choline and betaine. Therefore, to 
reduce information bias in study 2, 3 and 4, former smokers were combined with subjects 
who never smoke and only effect of current smoking vs. non-smoking was evaluated.  In 
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addition, physical activity was categorized in two contrasting groups: no and low vs. medium 
and high activity, because overestimation of real physical activity may cause overestimation 
its effect on choline and betaine in study 4.  
 
Confounding 
Confounding is a situation in which a third factor may explain (all or part of) the observed 
association between an exposure and outcome. A confounding factor (confounder) is a risk 
factor for the outcome (e.g. tHcy, choline and betaine) and it is associated with exposure (e.g. 
foods, nutrients), but not affected by exposure or disease (110). To reduce the effect of a 
possible confounder the observed associations should be adjusted for its effect. In our study, 
we assumed that age and gender might be possible confounders in the associations between 
predictors and plasma tHcy, choline and betaine. Therefore, we tested all associations in all 
the four sex and age groups, or adjusted for sex and age group. 
 
Major dietary predictors of plasma tHcy 
Because the aim of this study was to determine dietary predictors of plasma tHcy we assumed 
that the use of vitamin supplements might be a potential confounder. In stratified analysis by 
user/non-user of vitamin supplements, we observed differences in associations with several 
food groups and nutrients between non-users and users of vitamin supplements. In addition, 
considering that B-vitamin supplementation may substantially reduce plasma tHcy 
concentration and therefore reduce the effects of dietary factors, we excluded users of vitamin 
supplements for further in-depth analyses. We also adjusted, in multivariate analyses, for 
known risk factors for plasma tHcy, such as energy intake, smoking, coffee consumption, 
BMI and creatinine. 
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To test whether the observed associations between non-B-vitamins and tHcy concentration 
could be due to confounding effects of dietary B-vitamin intake (73, 74), we repeated the 
analyses using a model that included adjustment for dietary folate, vitamin B12, B6 and 
riboflavin and also for plasma folate and vitamin B12. 
 
Dietary fat as predictors of plasma tHcy 
We observed several important differences in associations between tHcy and FAs between 
younger and older individuals. Therefore, we stratified by age group. For the assessment of 
tHcy determinants, we considered the following variables to be potential confounders and 
adjusted for them in the multivariate models: sex, energy intake, daily smoking and coffee 
intake. We added the following additional variables as potential confounders: intake of 
vegetables and fruits for the association between other foods and tHcy; and intake of folate 
and vitamins B6 and B12 and riboflavin for the association between fat types and tHcy. In 
addition, we stratified individuals by dietary total B-vitamin score when we examined 
associations between VLC n-3 FAs and tHcy. Moreover, we excluded users of fish-oil and B-
vitamin supplements from further analysis. 
 
Predictors of plasma choline and betaine 
Because non-fasting samples were analyzed, we adjusted for time since last meal. Inclusion of 
this variable did however not materially change the observed associations. Because betaine 
concentration was higher with increasing energy intake, we also adjusted all association for 
total energy intake.We assumed that lifestyle factors, BMI and creatinine could be potential 
confounders in the associations between choline, betaine and diet, and therefore adjusted for 
these.  
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A potential important confounder could be menopausal status among women, especially in 
analyses of predictors of plasma choline (50). Unfortunately, we did not have information 
about the menopausal status of the youngest women. In premenopausal women the 
concentration of choline is higher then in postmenopausal women, as well as in men, due to 
de-novo synthesis of choline via PEMT. However, our results showed that plasma choline 
was higher in men than in women and it was higher in older women than in younger. 
Therefore, we do not think that confounding by menopausal status can explain our findings.  
 
Generalizability 
External validity refers to whether results of a study can be generalized to populations outside 
the study sample. The effect of diet on tHcy, may probably not vary according age and sex, 
while it may depend on vitamin supplements use. We observed associations between foods, 
drinks and nutrients, and plasma tHcy, choline and betaine in the same direction for men and 
women and for older and younger individuals supporting the external validity of our findings.  
 We believe that results reported here are generalizable to Norwegian men and women older 
than 47 years who do not use vitamin supplements. Our results may not be generalized to 
vitamin supplement users or populations with mandatory vitamin food fortification. In 
addition, our results can not be generalized to a population with different dietary habits or 
younger or ethnically different populations.  
 
The associations between choline and betaine with smoking, physical activity, body fat, blood 
lipids, glucose and blood pressure were in the same direction for men and women and for 
older and younger subjects. We believe that our results on components of metabolic syndrome 
may be generalized to all Norwegian population older than 47 years, as well as to populations 
with similar diet and lifestyle.  
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Discussion of specific results and comparison with other studies 
Diet 
Our findings show that consumption of foods rich in B-vitamins was inversely associated 
with tHcy level and positively associated with plasma betaine. A diet high in fat and sugar 
was related to higher plasma tHcy and lower plasma betaine concentrations. Saturated and 
monounsaturated fats were inversely related to betaine, while VLC n-3 FAs were inversely 
related to tHcy and positively related to betaine. In addition, intake of high-fiber bread was 
associated with higher plasma betaine, while alcohol consumption (except beer) was related 
to lower betaine concentration. Plasma choline was predicted by egg consumption and dietary 
cholesterol, but not by any identified dietary pattern. 
 
Users and non-users of vitamin supplements. In accordance with previous reports (63, 82, 
120, 121), we observed that users and non-users of vitamin supplements differed with respect 
to lifestyle, dietary habits and plasma vitamin concentrations. Users were more likely to be 
non-smokers, consume less coffee and generally have a more healthy diet compared to non-
users, they also had lower concentrations of plasma tHcy, and higher concentrations of folate 
and vitamin B12 as compared to non-users. There was an effect modification of vitamin 
supplement use on the association between several nutrients, food groups, and plasma tHcy. 
We are not aware that this has been previously reported. 
 
Nutrients. We observed divergent associations between plasma tHcy, choline and betaine and 
several nutrients. Our findings confirm previous studies reporting inverse associations 
between dietary intake of folate, vitamin B12, B6 and riboflavin, and plasma concentration of 
tHcy (12, 62, 68, 69). Among the four B-vitamins, the individual effect of folate was strongest 
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(68, 69).   In addition to being strongly inversely related to B vitamins, tHcy was also 
inversely related to vitamins C, E, D, retinol equivalent and beta-carotene, in accordance with 
previous reports (67, 74). The intake of these vitamins is correlated with the intake of B-
vitamins, indicating overlapping dietary sources. Plasma tHcy was also inversely related to 
complex carbohydrates and fiber. 
 
The strongest positive predictors of plasma betaine were complex carbohydrates, fiber, folate 
and thiamine. These relations may be explained by the high betaine content of grain products, 
which are also rich in complex carbohydrates, fiber, folate and thiamine. These findings are 
consistent with our finding of a positive association between plasma betaine and dietary 
patterns characterized by high content of high-fiber bread.  
 
While the inverse association between tHcy and fiber was no longer significant after 
adjustment for dietary B-vitamins, the inverse association with complex carbohydrates 
remained significant. This association could nevertheless be due to residual confounding from 
common dietary sources with B-vitamins. Another possible explanation relates to the 
construction and limitations of the food frequency questionnaire. Choline and betaine are not 
included in the Norwegian food composition tables, and we could therefore not examine 
whether the associations could be due to the dietary content of these factors. Some studies 
(88, 122) as well as the USDA National Nutrient Database for Standard Reference (123) 
report a high content of these quaternary ammonium compounds in some plant food. Inverse 
associations between intake and plasma concentrations of choline, betaine and plasma tHcy 
have been reported in previous studies (29, 57, 72).  
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Our finding of a strong positive association between SFAs and tHcy concentration is in 
agreement with findings in a population-based study in Ireland (75). It is possible that 
saturated fat intake stimulates PC synthesis via PEMT  (98, 124, 125), which causes an 
increase in plasma tHcy concentration (124, 125). Thus more methyl groups may be used for 
homocysteine remethylation (38, 41, 126).  
 
Previous studies have reported conflicting results on the effect of VLC n-3 FAs on plasma 
tHcy. Some studies observed an increase or no effect on tHcy concentrations after fish oil or 
fish powder (76, 78, 79) supplementation. However, other studies report reductions in tHcy in 
patients supplemented with fish oil (127, 128)  and an inverse relationship between plasma 
tHcy concentration and VLC n-3 FAs concentration in serum phospholipids (74, 77).  
 
The mechanism by which dietary VLC n-3 FAs could affect tHcy has not been elucidated. It 
is possible that consumption of VLC n-3 FAs decreases the synthesis of PC. Intake of VLC n-
3 FAs could stimulate carnitine (a derivative of betaine) formation (129) and BHMT activity 
(44). It has also been hypothesized that the effect could be due to modulation of gene 
expression of the enzyme(s) involved in Hcy synthesis (77).  
 
We found that the inverse association between plasma tHcy and VLC n-3 FAs intake was 
weakened by adjustment for intake of vitamins B6 and B12. This could be due to confounding 
introduced by simultaneous consumption of B6 and B12 rich foods: fish, for example, is a 
source of both VLC n-3 FAs and B-vitamins (101). In addition, our results may also suggest 
that individuals with high intake of marine oils have other dietary and lifestyle factors which 
are consistent with lower plasma tHcy concentration. It was suggested that tHcy may be 
reduced by a combination of B-vitamins and dietary n-3 fatty acids (12). We also found that 
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the inverse association between tHcy and VLC n-3 FAs intake occurred only at the highest 
intake level of B-vitamins. This effect was independent of fish-oil and B-vitamin supplement 
use. 
 
Food groups and food items.  As for nutrients, consumption of foods and beverages was 
divergently associated with plasma tHcy, choline and betaine. In line with previous studies 
(67, 81), we found inverse associations between plasma tHcy and dietary intake of citrus fruit, 
orange juice, cruciferous vegetables, spinach and peppers. In addition, we also found inverse 
relations with apples, carrots, onions, lettuce, cucumbers, tomatoes, and mushrooms. 
 
We observed, as have others, that plasma tHcy is inversely associated with fish intake (74). 
However, the association was confounded by simultaneous intake of B-vitamins. Fish was a 
component in a tHcy-lowering diet among elderly subjects (130) and a daily consumption of 
0.7 servings of fish in combination with other foods resulted in a significantly lower tHcy as 
compared to 0.3 servings (86) in a controlled feeding study in adults. However, these studies 
did not aim to assess the affect of fish as an individual food on tHcy level. 
 
Plasma tHcy was inversely associated with milk, as was previously reported (73, 81). A 
negative association between plasma tHcy and skim milk intake in adult men was observed by 
Oshaug et al. among oil platform workers (80). Moreover, skim milk intake was positively 
associated with choline in our study and intake of milk choline was inversely related to tHcy 
level in previous reports (72). Choline is a good source of methyl groups and a precursor of 
betaine. Thus, consumption of dietary choline may explain the inverse relation between milk 
intake and tHcy level. In addition, formation of PC via PEMT could be decreased due to high 
content of PC in milk (88). 
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As for milk, consumption of eggs was inversely related to tHcy level, while it was positively 
associated with choline concentration. Our observation that plasma choline showed strong 
association with egg consumption is in accordance with the high content of 
phosphatidylcholine in eggs. Thus, this finding may confirm our assumption that consumption 
of choline from diet could decrease the synthesis of PC via PEMT and hence, could reduce 
homocysteine concentration.   
 
Non-processed meat was inversely associated with tHcy, although the overall food group of 
meat was not significantly related to tHcy. Non-processed meat is a source of protein, 
vitamins B12, B6, riboflavin and choline which all are negatively associated with plasma tHcy 
(68, 69, 72). In addition, non-processed meat was positively associated with plasma choline 
because meat is a good source of dietary choline (72). However, the relation was observed 
only after adjustment for betaine concentration. It could be possible, that betaine is a 
confounder in the association between meat and choline.  
 
On the other hand, processed meat was positively associated with tHcy level. Processed meat 
contains less protein and B-vitamins and more fat than non-processed meat. Moreover, 
saturated fat is positively related to tHcy, and this may partly explain the positive association 
with processed meat (86).  
 
The intake of sweets and cakes, high in fat and sugar, was associated with high tHcy 
concentrations, consistent with our finding that the intake of simple carbohydrates (sugar) 
was negatively associated with dietary folate, vitamin B12, B6 and riboflavin. Betaine, 
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however, was inversely associated with sugar products and beverages. Thus, consumption of 
sugar may increase PC synthesis, and decrease betaine production from choline. 
 
The consumption of medium/high-fiber bread was inversely association with tHcy, but only 
after adjustment for B-vitamins in diet and plasma. According to previous reports (72) bread 
as a good source of dietary betaine was inversely associated with plasma tHcy level. In our 
analyses also high-fiber bread was the strongest predictor of plasma betaine. Thus, the 
relation between tHcy and bread may be explained by the high betaine content of grain 
products.  
 
Dietary patterns. Although in this study we did not examine dietary patterns in relation to 
tHcy, our results are in general agreement with studies that have done so (83-85, 87), namely 
inverse associations between tHcy and diets rich in fruits, vegetables, fish, meat, milk, whole 
grain bread and mushrooms (83-85). Dietary patterns high in refined cereals (85), fat (84, 86) 
and sugar have been associated with higher tHcy levels (87); this is also in agreement with 
our findings.  
 
To our knowledge this is the first study examining association between dietary patterns and 
plasma choline and betaine. The most striking findings were different associations of choline 
and betaine with dietary patterns and total energy intake. Choline was not related to any of the 
identified dietary patterns. On the contrary, betaine was inversely associated with a ‘Western’ 
dietary pattern. While betaine was positively related to total energy consumption, choline was 
not. Thus, results of the dietary pattern analysis is consistent with our findings that plasma 
choline could not be influenced by consumption of common foods or diets, while betaine 
concentration may vary according to dietary contents.  
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Other risk factors for CVD  
Neither choline nor betaine in plasma has previously been studied in relation to CVD risk 
factors. Recent studies on dietary choline and betaine have not found any association with 
CVD (32, 33). However, several established CVD risk factors (131), including older age, 
male gender, smoking, physical inactivity and high tHcy levels are associated with plasma 
choline and betaine. As interrelated metabolic compounds involved in methionine and lipid 
metabolisms, choline and betaine show the associations with CVD risk factors in the same 
direction.  
 
Our observation that plasma choline is higher in men than in women and in older women than 
in younger women are opposite to what may by expected from animal studies demonstrating 
stimulation of PEMT and thereby phosphatidylcholine synthesis by estrogens (47, 132), 
suggesting additional effect from sex hormones on choline metabolism and distribution.  
 
Both plasma choline and betaine were inversely associated with plasma tHcy level, as 
reported previously (29, 38, 41, 72). Choline showed a positive relation to betaine as the 
immediate metabolic precursor of betaine (57). The association between choline and betaine 
was similar to previously reported results (41, 103, 126). In addition, choline was 
significantly lower in smokers compared to non-smokers, but only in men. The mechanism by 
which smoking relate to choline metabolism is yet not understood. 
 
Compared to plasma choline, plasma betaine showed a similar but stronger relation to gender 
and tHcy in the present, as well as in previous studies (38, 41, 57). The strong effect of gender 
may be explained by transcriptional regulation of human BHMT by estrogen and androgen 
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(133). In addition, betaine was higher in individuals with higher physical activity, which 
could be due to healthier lifestyle in these subjects in general and dietary folate intake in 
particular. Moreover, the relation with physical activity could be explained by increased 
oxidation rate in mitochondria, discussed below (134, 135). 
 
Components of metabolic syndrome  
Despite the close metabolic link between choline and betaine, they show divergent 
associations with several components of the metabolic syndrome. Because the correlation 
between choline and betaine is moderate (r=0.37), it is not inconsistent with divergent 
associations with a third factor, i.e. key element(s) of the metabolic syndrome. 
 
Choline is associated with BMI, percent body fat, waist circumference, HDL cholesterol and 
TGs in the opposite direction (to betaine) but is not associated with non-HDL cholesterol and 
blood pressure. The relation between choline and blood lipids are in agreement with the 
observation that PC supplementation in humans increases TGs, but does not affect cholesterol 
concentrations (31). Experimental studies in mice show that high-fat feeding leads to weight 
gain, elevated triglycerides, hyperinsulinemia and glucose intolerance in choline-replete 
animals, whereas choline-deficiency increases TG stores in liver (53).  
 
Betaine is inversely associated with several components of the metabolic syndrome (93) in 
the direction that decreases CVD risk. These factors include BMI, percent body fat, waist 
circumference, systolic and diastolic blood pressure, non-HDL cholesterol, HDL cholesterol 
and TGs. These observations gain some support from results published by others. In subjects 
attending a lipid clinic, betaine was inversely related to body fat and Apo B (44). Betaine 
supplementation has been shown to reverse an atherogenic lipid profile in mice (136) and to 
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decrease body fat in pigs (137, 138). However, in humans, high doses of 4-6 g betaine daily 
increased total cholesterol, LDL cholesterol and TGs (31, 39). It is possible that endogenous 
and dietary betaine may have different effects on lipid metabolism, and that the effects of 
betaine supplementation may vary according to dose, duration and also between species. 
 
Diet and the metabolic syndrome.  Conceivably, the relations of plasma free choline and 
betaine to components of the metabolic syndrome may reflect the influence of dietary patterns 
and recent intake of specific food items. We observed a weak inverse association between 
choline and betaine concentrations and time since last meal, but adjustment for this time 
interval did not materially affect the results. Furthermore, energy intake showed no relation to 
plasma choline but a positive relation to plasma betaine.  
 
The metabolic syndrome has been linked to dietary intake. Although somewhat inconsistent 
results have been obtained, the prevailing view is that a “Healthy” or prudent diet, with high 
amounts of fruits, vegetables, legumes, whole grain, poultry, and low-fat dairy products is 
beneficial. An energy dense ‘Western’ diet rich in refined grains, cakes, sugar and red meat, 
fried food and butter is adversely associated with the metabolic syndrome (139-141). 
However, food items rich in choline (88) such as eggs, low-fat meat and milk, are not 
necessarily components of an unhealthy dietary pattern. For example, in healthy adults, there 
was an inverse relation between choline intake and concentrations of inflammatory markers 
related to atherogenesis (94). Furthermore, high fat dairy products, cakes and sweets are low 
in choline. Likewise, the betaine content in most fruits and vegetable (except beets and 
spinach) is low (88).  
 
Because wheat bran and germ are good sources of betaine (88), it could be argued that the 
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inverse association between plasma betaine and component of the metabolic syndrome is 
attributable to the consumption of whole wheat. However, even though the interindividual 
variation of plasma betaine is substantial (up to 10-fold differences between individuals), the 
intraindividual variability is small, with an individual set point that remains stable for years 
(142). This suggests that plasma betaine is under strict metabolic control and justifies the 
concept of betaine status as a component of an individual’s homeostasis. 
 
Conceivably, the observed divergent relations of plasma choline and betaine with components 
of the metabolic syndrome could reflect diet if high intakes of meat increase plasma choline 
and high intakes of vegetables increase betaine. However, this possibility is not in agreement 
with the observations that neither plasma choline nor betaine was related to the ‘Meat’ or 
‘Vegetables’ dietary patterns. Furthermore, cholesterol, probably derived from intake of eggs, 
was the only nutrient associated with plasma choline, which showed no association with 
serum non-HDL cholesterol. These observations support the contention that the link between 
plasma choline and betaine and the metabolic syndrome may not reflect dietary intake. 
 
Possible mechanisms.Central obesity and increased biologic activity of the upper visceral 
adipose tissue with excessive flux of fatty acids are regarded as primary factors of the 
metabolic syndrome, leading to insulin resistance and atherogenic dyslipidemia (93). Both 
BHMT and choline dehydrogenase in rat liver are decreased by insulin and increased in 
diabetes (143). In addition, a general mitochondrial dysfunction prevails in the metabolic 
syndrome (144), which may involve choline oxidation to betaine (145). Thus, the metabolic 
syndrome including insulin resistance may be associated with a disruption of the choline 
dehydrogenase pathway in the motochondria. Moreover, this disruption could be possible 
when excessive flux of fatty acids requires choline for PC synthesis (98) and VLDL secretion 
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(146).  
 
Recent studies suggest a role of BHMT in lipid metabolism (147). Dietary BHMT induction 
in rats resulted in an increase in liver apoprotein, TGs production and VLDL secretion (147). 
These are features suggesting roles in addition to homocysteine remethylation for this enzyme 
(133). Thus, BHMT may represent a metabolic link between lipid and methionine 
metabolism. 
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6    CONCLUSIONS 
Our findings from this Norwegian adult and elderly population sample indicate that diet 
influences the concentrations of plasma betaine and tHcy. A diet rich in B-vitamins and with 
a low content of fat and sugar is related to higher plasma betaine and lower tHcy levels.  
In a population not taking vitamin supplements, plasma tHcy concentration may be lowered 
with a diet rich in complex carbohydrates, protein, and B-vitamins. Such a diet includes 
vegetables, fruits, whole grain bread and cereals, as well as fish, non-processed meat, chicken, 
and eggs. Moreover, a diet rich in complex carbohydrates, fiber, folate and vitamin B6 is 
related to higher plasma betaine level. Plasma choline was less influenced by diet, and was 
only positively associated with eggs, skim milk and beer. 
 
On the other hand, a high consumption of dairy fat and sugar-rich foods may decrease plasma 
betaine and increase tHcy concentration. In addition, the inverse association between dietary 
intake of VLC n-3 FAs and plasma tHcy may be explained by the positive relation of betaine 
to VLC n-3 FAs and by simultaneous consumption of B-vitamins from the same food source.  
 
In addition, the present study demonstrates that key components of the metabolic syndrome 
including body composition, blood lipids and glucose are related to plasma choline and 
betaine. An increased CVD risk factor profile is associated with low betaine and high choline 
levels. These divergent associations of the substrate (choline) and product (betaine) may 
reflect disruption of the mitochondrial choline dehydrogenase pathway. Low choline 
oxidation may be caused by a diet high in saturated fat and sugar. Thus, a Western style diet 
leading to decreased choline oxidation may influence the concentration of both betaine and 
tHcy in plasma and hence, increase the risk for CVD. 
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7    FUTURE STUDIES 
Future studies should examine betaine content in common foods and beverages in order to 
evaluate total consumption of dietary betaine and its effect on betaine and tHcy in plasma. 
Moreover, whether this effect is independent of dietary B-vitamins also should be evaluated. 
In addition, consumption of dietary choline  (62, 72) should be assessed in relation to plasma 
choline and tHcy levels. 
  
To confirm the relation between dietary patterns and plasma betaine, more studies should 
examine the affect of ‘healthy’ and ‘unhealthy’ dietary patterns on plasma betaine level using 
confirmatory factor analysis.  
 
More large observational and intervention studies are needed to confirm our findings on 
association between VLC n-3 FAs intake and plasma betaine and tHcy. In addition, future 
studies should assess an effect of saturated fat and sugar/glucose on plasma choline, betaine 
and tHcy levels.  
 
Further investigations should confirm the relations of CVD risk factors and key components 
of the metabolic syndrome (body composition, lipid profile, glucose and blood pressure) to 
plasma choline and betaine levels. Moreover, choline and betaine levels should be evaluated 
in relation to non-alcoholic fatty liver disease. 
 
To confirm an assumption that the link between plasma choline and betaine and the metabolic 
syndrome may not reflect merely dietary intake of choline or betaine, but rather a disruption 
of mitochondrial choline dehydrogenase pathway (145) by FAs, the affect of different diets 
(low SFAs vs. high SFAs and low VLC n-3 FAs vs. VLC n-3 FAs) on choline dehydrogenase 
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activity should be tested. In addition, the general mitochondrial dysfunction that prevails in 
the metabolic syndrome (144), should be examined in response to different diets in obese and 
healthy subjects.  
 
More studies on humans should be done to test our assumption that plasma choline and 
betaine concentrations may vary according enzyme activities, BHMT (133) and choline 
dehydrogenase (145), as well as of PC synthesis (148, 149). Effect of insulin on the enzymes 
activity should be assessed in diabetes and healthy humans (143).  
 
Intervention studies are needed to test the inverse relations between plasma betaine and 
alcohol and between choline and coffee consumption. In addition, choline and betaine level 
should be evaluated in relation to kidney function.  
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HVA SPISER DU?
I dette skjemaet spør vi om dine spisevaner slik de vanligvis er.
Vi er klar over at kostholdet varierer fra dag til dag. Prøv derfor 
så godt du kan å gi et "gjennomsnitt" av dine spisevaner. Ha det
siste året i tankene når du fyller ut skjemaet. Der du er usikker,
anslå svaret.
Skjemaet skal leses av en maskin, og derfor er det viktig at du
setter et tydelig kryss i avmerket rute.
Riktig markering er slik:
Bruk helst bløt blyant. Feil kan da rettes med viskelær.
Kulepenn og svart tusjpenn kan også brukes.
Av hensyn til den maskinelle lesingen pass på at arkene ikke blir brettet.
Alle svar vil bli behandlet strengt fortrolig.
EKSEMPEL PÅ UTFYLLING AV SPØRSMÅL 1.
Kari Nordmann spiser daglig 5 skiver brød og ett
knekkebrød. Hun spiser vanligvis kneippbrød, men i helgene
blir det en del loff. I tillegg spiser hun ett knekkebrød hver
dag. Hun fyller ut første spørsmål slik:
1.HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Fint brød
(loff, baguetter, fine rundstykker o.l.)
Mellomgrovt brød
(lys helkorn, lys kneipp, lyst hj.bakt o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj.bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
0 1/2 1 2 3 4 5 6 7 8 9 10 11 12+
Antall skiver pr. dag
Sum skiver pr. dag = ____
Antall skiver pr. uke: _______ = ____  Tallet brukes i spørsmål 5.
6
6 x 7 42
2.HVA PLEIER DU Å SMØRE PÅ 
BRØDET?
Merk av både for hverdag og helg, selv
om du bruker det samme.
3.OM DU BRUKER 
FETT PÅ BRØD, HVOR
MYE BRUKER DU?
4.MELK SOM DRIKK
(1 glass = 1,5 dl)
1.HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Fint brød
(loff, baguetter, fine rundstykker o.l.)
Mellomgrovt brød
(lys helkorn, lys kneipp, lyst hj.bakt o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj.bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
0 1/2 1 2 3 4 5 6 7 8 9 10 11 12+
Antall skiver pr. dag
Sum skiver pr. dag = ____
Antall skiver pr. uke: ____ x 7 = ____. Tallet brukes i spørsmål 5.
Hverdager Lørdager, søndager En porsjonspakning på 12 g
rekker til antall skiver
Bruker ikke
1/2 1 2 3 4 5 6 7 8+
Drikker
sjelden/
ikke
Antall glass pr. dag
1
5
4
3
2
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3
Smør   (meierismør)
Bremykt, Smøregod
Brelett
Soft, soyamargarin (pakke, beger)
Solsikke
Oliven
Vita
Olivero
Omega
Soft light
Vita lett
Annen margarin
Helmelk, søt, sur
Lettmelk, søt, sur
Lettmelk, ekstra lett
Skummet melk, søt, sur
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5.PÅLEGGSSORTER
Bruk sum skiver pr. uke fra spørsmål 1.
Brun ost, prim
Hvit ost, helfet, 27% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)
Hvit ost, halvfet, 16% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)
Ost med mer enn 27% fett
(kremoster, Normanna, Ridderost)
Leverpostei, vanlig
Leverpostei, mager
Servelat, vanlig
Lett servelat, kalverull,
kokt skinke, okserull o.l.
Salt pølse, spekepølse
(fårepølse, salami o.l.)
Kaviar
Sardiner, sursild, ansjos o.l.
Makrell i tomat, røkt makrell
Laks, ørret
Syltetøy, marmelade, frysetøy
Reker, krabbe
Honning, sirup,
sjokolade-, nøttepålegg
Majones på smørbrød
Grønnsaker som pålegg
(agurk, tomat o.l.)
Frukt som pålegg (banan, eple o.l.)
Salater med majones
(kokt, stekt, eggerøre, omelett)
6.EGG
0
Til antall skiver pr. uke
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 enn 1 1 3-4 5-6 7 8+2
Mindre Antall pr. uke
4
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8. KAFFE OG TE
(1 kopp kaffe = 1,2 dl    1 kopp te = 2 dl)
7. FROKOSTGRYN, GRØT OG YOGHURT
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Melk søt, sur på gryn,
grøt og dessert
Havregryn, kornblandinger
(4-korn, usøtet müsli o.l.)
Cornflakes, puffet ris,
havrenøtter o.l.
Havregrøt
Sukker til frokostgryn, grøt
Yoghurt, naturell, frukt
Lettyoghurt
Go´morgen yoghurt
inkl. müsli
Kaffe, kokt
Kaffe, traktet, filter
Kaffe, pulver (instant)
Kaffe, koffeinfri
Te
Nypete, urtete
Sukker til kaffe
Sukker til te
Fløte til kaffe
Kunstig søtstoff til kaffe eller te
0 1/2 1 2 3
Antall teskjeer eller biter pr. kopp
4+
1/2 1 3-42 5-6
Antall kopper pr. dag
7-8
Drikker
ikke/ikke
daglig 9-10 11+
2-3
Gang pr. måned Gang pr. uke Mengde pr. gang
4-5 6-7 8+1321<10
1 1 1/2 2 3+
1 1 1/2 2 3+
1-2 3-4 5-6 7+
1 2 3-4 5+
1/2 1 1 1/2 2+
1/2 1 1 1/2 2+
1/2 1 1 1/2 2+
3/4 1 2 3+
(dl)
(dl)
(dl)
(ts)
(beger)
(beger)
(beger)
(dl)
5
Taco (med kjøtt og salat)
Pastaretter
Alkoholfritt øl, vørterøl,
lettøl
Kjøttdeigretter (saus eller gryte
med kjøttdeig, lasagne o.l.)
9. ANDRE DRIKKER?
Svar enten pr. måned eller pr. uke.  < 1 betyr sjeldnere enn 1 gang.
Merk at porsjonsenhetene er forskjellige. 1/3 liter tilsvarer en halvflaske øl 
og 2/3 liter tilsvarer en helflaske.
Vann
Appelsinjuice
Annen juice, most, nektar
Saft, solbærsirup
m. sukker
Saft, kunstig søtet
Brus, Cola, Solo o.l.,
med sukker
Brus, Cola, Solo o.l.,
kunstig søtet
Farris, Selters, Soda o.l.
Pilsnerøl
Vin
Brennevin, likør
Kjøttpølse, medisterpølse
Hamburger, karbonader o.l.
Grill- og wienerpølse
Kjøttkaker, medisterkaker,
kjøttpudding
Hamburger-, pølsebrød,
lomper
2
Gang pr. måned
1<10 3 4 5-6 7-8 9+
(kjøttpølse)
(stk)
(pølse)
(stk)
(stk)
(dl)
(stk)
(dl)
Gang pr. måned Gang pr. uke Mengde pr. gang
0 <1 1 2 3 1 2-3 4-5 6-7 8+
(glass)
(glass)
(glass)
(glass)
(glass)
(liter)
(liter)
(liter)
(liter)
(liter)
(glass)
(1 dram
= 4 cl)
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1 2 3 4 5
1 2 3 4 5
5+
5+
5+
5+
5+
11/2+
11/2+
11/2+
6+
6+
11/2+
11/2+
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10. MIDDAGSRETTER
Vi spør både om middagsmåltidene og det du spiser til andre måltider. Tell til slutt
sammen antall retter du har merket for og se om summen virker sannsynlig.
En "dl" tilsvarer omtrent mengden i en suppeøse. Med "ss" menes en spiseskje.
Mengde pr. gang
1/2 2/3 1 2+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
11/2
6
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Pizza (500-600 g)
Koteletter (lam, okse, svin)
Biff (alle typer kjøtt)
Stek (elg, hjort, reinsdyr o.l.)
Stek (lam, okse, svin)
Gryterett med helt kjøtt,
frikassé, fårikål o.l.
Lapskaus, suppelapskaus,
betasuppe
Bacon, stekt flesk
Kylling, høne
Torsk, sei, hyse (kokt)
Leverretter
Fiskekaker, fiskepudding,
fiskeboller
Fiskepinner
Torsk, sei, hyse (stekt, panert)
Sild (fersk, speket, røkt)
Makrell (fersk, røkt)
Laks, ørret (sjø, oppdrett)
Fiskegryte, -grateng, suppe
med fisk
Reker, krabbe
Risgrøt, annen melkegrøt
Pannekaker
Suppe (tomat, blomkål,
ertesuppe o.l.)
Vegetarrett, vegetarpizza
grønnsakgrateng, -pai
Brun/hvit saus
Smeltet margarin, smør
til fisk
Bearnaisesaus o.l.
Majones, remulade
Ketchup
2
Gang pr. måned
(pizza)
(stk)
(stk)
(skive)
(skive)
(dl)
(dl)
(skive)
(stk)
(skive)
(kake)
(stk)
(stk)
(stk)
(filet)
(filet)
(skive)
(dl)
(dl, renset)
(dl)
(stk)
(dl)
(bit/dl)
(dl)
(ss)
(ss)
(ss)
(ss)
Mengde pr. gang
1<10 3 4 5-6 7-8 9+
1/8 1/4 1/2 3/4 1+
21<10 3 4 5-6 7-8 9+
21<10 3 4 5-6 7-8 9+
21<10 3 4 5-6 7-8 9+
1/2 1 1 1/2 2 2 1/2+
1-2 3-4 5-6 7-8 9+
1/4 1/3 1/2 3/4 1+
1 2 3 4 5+
1/2 1 1 1/2 2 3+
1-2 3-4 5-6 7-8 9+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 1 1/2 2 2 1/2+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-9 10+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/2 1 1 1/2 2 2 1/2+
7
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11. POTETER, RIS, SPAGHETTI, GRØNNSAKER
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Disse spørsmålene dreier seg først og fremst om tilbehør til middagsretter, men
spiser du for eksempel en rå gulrot eller salat til lunsj, skal det tas med her. 
0
Gang pr. måned Gang pr. uke Mengde pr. gang
<1 1 2 3 1 2-3 4-5 6-7 8+
Poteter, kokte
Pommes frites, stekte
poteter
Potetmos, -stuing,
gratinerte poteter
Ris
Spaghetti, makaroni,
pasta
Gulrot
Hodekål
Kålrot
Blomkål
Brokkoli
Rosenkål
Grønnkål
Løk
Spinat, andre bladgrønns.
Sopp
Avocado
Paprika
Tomat
Tomatbønner, bønner/linser
Mais
Erter, frosne grønnsak-
blandinger
Salatblandinger
Dressing
Rømme
Hvor mange ganger om dagen spiser du vanligvis
grønnsaker utenom grønnsakene du spiser til middag?
(stk)
(dl)
(dl)
(dl)
(dl)
(stk)
(skalk)
(skive)
(bukett)
(bukett)
(stk)
(dl)
(ss)
(dl)
(stk)
(stk)
(strimmel)
(stk)
(dl)
(ss)
(dl)
(dl)
(ss)
(ss)
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 2 3 4+
1/2 1 2 3 4+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/2 1 1 1/2 2 3+
1/4 1/2 3/4 1 1 1/4 +
1/2 1 1 1/2 2 3+
0 1 2 3 4 5+
8
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12. TYPE FETT TIL MATLAGING
13. FRUKT
Svar enten pr. måned eller pr. uke. < 1 betyr sjeldnere enn 1 gang.
Hvor mange frukter spiser du vanligvis pr. dag? 0 1 2 3 4 5 6
9
Smør (meierismør)
Bremykt
Melange, Per
Soft-, soyamargarin (pakke, beger)
Solsikke
Oliven
Olivenolje
Soyaolje
Maisolje
Solsikkeolje
Valnøttolje
Andre oljer
Annen margarin
Smør/margarin Oljer
Mengde pr. gang
Eple 0
Appelsin, mandarin,
grapefrukt
Banan
Druer
Eksotisk frukt (kiwi, mango)
Annen frukt (fersken,
pære m.v.)
Jordbær, bringebær
(friske, frosne)
Blåbær
Gang pr. måned Gang pr. uke
<1 1 2 3 1 2-3 4-5 6-7 8+
(stk)
(stk)
(stk)
(klase)
(stk)
(stk)
(dl)
(dl)
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
Multer (dl)
1/2 1 2 3+
7 8 9+
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14. DESSERT, KAKER, GODTERI
Svar enten pr. måned eller pr. uke. < 1 betyr sjeldnere enn 1 gang.
Hermetisk frukt, fruktgrøt
Puddinger (sjokolade,
karamell o.l.)
Is (1 dl = 1 pinne = 1
kremmerhus)
Boller, julekake, kringle
Skolebrød, skillingsbolle
Wienerbrød, -kringle o.l.
Smultring, formkake
Vafler
Sjokoladekake, bløtkake,
annen fylt kake
Søt kjeks, kakekjeks
(Cookies, Bixit, Hob Nobs)
Sjokolade (60 g)
Drops, lakris, seigmenn o.l.
Smågodt (1 hg = 100g)
Potetgull (1 pose 100g = 7 dl)
Annen snacks (skruer, crisp,
saltstenger, lettsnacks o.l.)
Peanøtter, andre nøtter
(1 pose 100g = 4 never)
Gang pr. måned Gang pr. uke Mengde pr. gang
0 <1 1 2 3 1 2-3 4-5 6-7 8+
(dl)
(dl)
(dl)
(stk)
(stk)
(stk)
(stk)
(stk)
(stk)
(stk)
(plate)
(plate)
(hg)
(dl)
(dl)
(neve)
1/2 3+21
1/2 3+21
1/2 3+21
1 4+32
1 4+32
1 4+32
1 4+32
1 4+32
1 4+32
1 4+32
1-2 7+5-63-4
1-2 7+5-63-4
1-2 7+5-63-4
1-2 7+5-63-4
1/2 1 1/2+13/4
1/2 3+21
10
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15. KOSTTILSKUDD (bs = barneskje, ts = teskje)
Tran
Trankapsler
Fiskeoljekapsler
Multipreparater
Sanasol
Biovit
Vitaplex
Kostpluss
Vitamineral
Annet
Jernpreparater
Ferro C
Hemofer
Duroferon
Duretter
Annet
B-vitaminer
C-vitamin
D-vitamin
E-vitamin
Folat (folsyre)
Kalktabletter
Fluortabletter
Annet
Hvis annet, hvilket? ..................................................................
Hvis annet, hvilket? ..................................................................
Hvis annet, hvilket? ..................................................................
Gang pr. uke
6-7
Mengde pr. gang
4-52-31<10
6-74-52-31<10
6-74-52-31<10
6-74-52-31<10
6-74-52-31<10
kapsler
kapsler
bs
bs
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
1 ts 1 bs 1 ss
1 2+
1-2 3-4 5-6 7+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
Hele
året
Bare vinter-
halvåret
11
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16. NÅR SPISER DU PÅ HVERDAGER?
17. MENER DU SVARENE I SPØRRESKJEMAET GIR
ET BRUKBART BILDE AV KOSTHOLDET DITT?
18. ER DU FORNØYD MED KROPPSVEKTEN DIN SLIK DEN ER NÅ?
19. KJØNN
Vennligst se etter at du har svart på alle spørsmål.
Takk for innsatsen!
HOVEDMÅLTIDER som frokost, formiddagsmat, middag, kvelds.
MELLOMMÅLTIDER som kaffe, frukt, godteri, snacks m.v.
Er det matvarer/produkter du regelmessig bruker, og som ikke er nevnt i skjemaet?
.................................................................................................................................
.................................................................................................................................
6 8 10 12 14 16 18 20 22 24 2 4
6 8 10 12 14 16 18 20 22 24 2 4
Ja Nei
Ja
Nei, jeg ønsker å slanke meg
Nei, jeg ønsker å legge på meg
Mann Kvinne
Omtrent klokken
Omtrent klokken
12
